COVID-19 in children and altered inflammatory responses
暂无分享,去创建一个
[1] E. Molloy,et al. Neonatal sepsis: need for consensus definition, collaboration and core outcomes , 2020, Pediatric Research.
[2] H. Yoon,et al. Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice , 2016, Oxidative medicine and cellular longevity.
[3] Xiaoqing Lu,et al. Possible causes for decreased susceptibility of children to coronavirus , 2020, Pediatric Research.
[4] R. Hotchkiss,et al. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.
[5] Guangyou Duan,et al. A prospective observational cohort study , 2016 .
[6] Huixia Yang,et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.
[7] Mitchell R. Ladd,et al. A Dynamic Variation of Pulmonary ACE2 Is Required to Modulate Neutrophilic Inflammation in Response to Pseudomonas aeruginosa Lung Infection in Mice , 2019, The Journal of Immunology.
[8] D. Schwartz,et al. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. , 2020, Archives of pathology & laboratory medicine.
[9] Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] T. van der Poll,et al. Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study , 2019, Annals of Intensive Care.
[11] Michael T. Bigham,et al. The Influence of Developmental Age on the Early Transcriptomic Response of Children with Septic Shock , 2011, Molecular medicine.
[12] J. Mikes,et al. Stereotypic Immune System Development in Newborn Children , 2018, Cell.
[13] Zhongyi Jiang,et al. Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.
[14] Yan Chen,et al. Infants Born to Mothers With a New Coronavirus (COVID-19) , 2020, Frontiers in Pediatrics.
[15] N. Shinomiya,et al. An in vitro Shwartzman reaction‐like response is augmented age‐dependently in human peripheral blood mononuclear cells , 2006, Journal of leukocyte biology.
[16] A. Singanayagam,et al. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? , 2020, The Lancet.
[17] Zhongyi Jiang,et al. Epidemiology of COVID-19 Among Children in China , 2020, Pediatrics.
[18] Lei Zhang,et al. Effects of angiotensin II type 1 receptor antagonist on rats with septic shock. , 2015, International journal of clinical and experimental medicine.
[19] Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy , 2020, Pediatric Research.
[20] A. Teixeira,et al. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research. , 2017, Current drug targets.
[21] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[22] J. Chiche,et al. Timing and causes of death in septic shock , 2015, Annals of Intensive Care.
[23] P. Gressens,et al. Ontogeny of cytokine responses to PHA from birth to adulthood , 2019, Pediatric Research.
[24] M. Martínez. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus , 2020, Antimicrobial Agents and Chemotherapy.
[25] Sharon Einav,et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 , 2020, Journal of Critical Care.
[26] H. Wong,et al. Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.